A study comparing the long-term safety of two investigational drugs in adult and adolescent African-American subjects with asthma
The goal of this study is to assess the long-term safety of two investigational drugs in African-American subjects with moderate to severe asthma. The study is one year in duration and will include nine visits.
You may be eligible to participate in this study if you:
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.